Breast Cancer

Bone loss an important consideration in endocrine therapy for breast cancer.

Bone health has become an increasingly important consideration in the management of oestrogen receptor-positive early breast cancer. A position statement summary, published in the MJA, has emphasised the need for bone health to be taken into account in the decision-making process regarding initial choice and duration of endocrine therapy. As well, bone health should be assessed ...

Already a member?

Login to keep reading.

© 2021 the limbic